2 result(s) for
| PI Name | Protocol # | Title |
|---|---|---|
| Zahi Mitri | STUDY00020440 | A Modular, Multipart, Multiarm, Open-label, Phase I/IIa Study to Evaluate the Safety and Tolerability of CT7001 Alone and in Combination with Anti-cancer Treatments in Patients with Advanced Malignancies |
| Zahi Mitri | STUDY00022395 | A Randomized, Phase II Trial of Circulating Tumor DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Stage II-III, Estrogen Receptor Positive, HER2-negative Breast Cancer (DARE) |
You may also qualify for Phase 1 Program trials.